Non-invasive DHM and its unique advantages for cell phenotype measurements

In this video, Dr. Kersti Alm, CSO, Phase Holographic Imaging, presents a talk that she gave at the National Institute of Standards and Technology (NIST) 2022 workshop on measurement needs for the biofabrication of tissue-engineered medical products. During the presentation, she introduces the label-free HoloMonitor^® technology for digital holographic microscopy and provides an overview of its unique advantages for minimally destructive cell phenotype measurements.